ALDX (STOCKS)
Aldeyra Therapeutics, Inc.
$1.510000
-0.010000 (-0.66%)
Prev close: $1.520000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Todd C. Brady
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $87.17M
- Employees
- 8
- P/E (TTM)
- -3.76
- P/B (TTM)
- 2.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | $1.01M |
| Research and Development | $15.63M |
| Operating Income/Loss | -$24.07M |
| Income/Loss From Continuing Operations After Tax | -$23.05M |
| Income/Loss From Continuing Operations Before Tax | -$23.05M |
| Net Income/Loss | -$23.05M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$23.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$23.05M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.38 |
| Diluted Earnings Per Share | -$0.38 |
| Basic Average Shares | 180,803,001 |
| Diluted Average Shares | 180,803,001 |
| Assets | $47.54M |
| Current Assets | $47.38M |
| Noncurrent Assets | $161.65K |
| Fixed Assets | $20.54K |
| Other Non-current Assets | $141.11K |
| Liabilities | $9.66M |
| Current Liabilities | $9.66M |
| Accounts Payable | $137.48K |
| Wages | $1.93M |
| Other Current Liabilities | $7.59M |
| Noncurrent Liabilities | $0.00 |
| Equity | $37.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $37.89M |
| Liabilities And Equity | $47.54M |
| Net Cash Flow From Operating Activities | -$22.02M |
| Net Cash Flow From Operating Activities, Continuing | -$22.02M |
| Net Cash Flow From Investing Activities | $40.98M |
| Net Cash Flow From Investing Activities, Continuing | $40.98M |
| Net Cash Flow From Financing Activities | -$15.11M |
| Net Cash Flow From Financing Activities, Continuing | -$15.11M |
| Net Cash Flow | $3.85M |
| Net Cash Flow, Continuing | $3.85M |
| Comprehensive Income/Loss | -$23.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$23.04M |
| Other Comprehensive Income/Loss | -$13.13M |
| Other Comprehensive Income/Loss Attributable To Parent | $11.00K |